Fundz

Fundz Deep Dive

Everything you need to win Nagaraja Srivatsan — in one platform.

Who to reach, what to say, and why now on Nagaraja Srivatsan — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Nagaraja Srivatsan — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Endpoint Clinical Appoints Nagaraja Srivatsan As Chief Executive Officer

PRIVATEMar 20, 2025•about 1 year ago

Position

Chief Executive Officer

Company

Endpoint Clinical

Nagaraja Srivatsan
RaleighManufacturingBiotechnologyHealth CareMedical

Description

Endpoint Clinical has appointed Nagaraja Srivatsan as its Chief Executive Officer. As the new CEO, Srivatsan will focus on advancing Endpoint's technology suite, expanding its market presence, scaling operations, and delivering solutions that enhance and accelerate the clinical trial process.

Company Information

Company

Endpoint Clinical

Location

Raleigh, North Carolina, United States

About

Endpoint Clinical is a trusted clinical trial technology and service partner that delivers reliable RTSM solutions. Endpoint seamlessly integrates into clinical trial processes by providing anticipatory and adaptive solutions that proactively mitigate risks. With decades of experience in the field, Endpoint deeply understands the challenges manufacturers face in clinical trials. The company's tech-forward approach, commitment to innovation, and strategic investments enable it to proactively develop fast and effective solutions, allowing manufacturers to focus on seamless clinical trials.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Endpoint Clinical's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.